Although comorbidities like type 2 diabetes, liver disease, and kidney disease may influence inflammation, hepcidin, and erythropoiesis, they may also lie on the causal pathway from adiposity to haemoglobin. The gene discussed is HAMP; the disease is type 2 diabetes mellitus.